[Review of changes introduced by the new WHO classification (4th edition) of myeloid neoplasms. An overview].
Komatsu
Norio
N
D019046:Bone Marrow Neoplasms / Q000145:classification* / Q000235:genetics; D006801:Humans; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000145:classification* / Q000235:genetics; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics; D014944:World Health Organization
C496348:FGFR1 protein, human; D051496:Receptor, Fibroblast Growth Factor, Type 1; D020796:Receptor, Platelet-Derived Growth Factor alpha; D020797:Receptor, Platelet-Derived Growth Factor beta